Moreover, 10 % (1/10) of SCCO patients, 38 % (6/16) of SCCO-HT patients, and 59 % (10/17) of NET-O patients expressed MGMT, while 13 % of SCLC patients (7/55) expressed MGMT. The gene discussed is MGMT; the disease is small cell lung carcinoma.